Long-term MOno-Antiplatelet Drug Strategy After PerCutanEous CoronAry InterveNtion
NCT03725800 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2018-10-31
Summary
The OCEAN (long-term mOn-antiplatelet drug strategy after perCutanEous coronANy intervention) study is the largest prospective multicenter data base to investigate the long-term incidence and prognosis of the use of agents for antiplatelet-induced GI injury symptoms (AI-GIS) or GI hemorrhage among patients undergoing PCI. The OCEAN study will provide evidence of the long-term incidence and prognosis of use of agents for AI-GIS among patients undergoing PCI. It has the potential to provide an optimal long-term mono-antiplatelet strategy.
Conditions
- Antiplatelet Drug-related Gastrointestinal Injury
Sponsors & Collaborators
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
collaborator OTHER -
The First Affiliated Hospital of Guangdong Pharmaceutical University
collaborator OTHER -
Guangzhou Panyu Central Hospital
collaborator OTHER -
First People's Hospital, Shunde China
collaborator OTHER -
Second People's Hospital of Foshan City
collaborator UNKNOWN -
The First People's Hospital of Qingyuan
collaborator UNKNOWN -
Zhongshan People's Hospital, Guangdong, China
collaborator OTHER -
Huadu District People's Hospital of Guangzhou
collaborator OTHER -
Guangdong Provincial People's Hospital
lead OTHER
Principal Investigators
-
Yong Liu, MD,PhD · Guangdong Cardiovascular Institute,Guangdong General Hospital
-
Shiqun Chen, MS · Guangdong Cardiovascular Institute,Guangdong General Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-15
- Primary Completion
- 2019-10-31
- Completion
- 2019-11-30
Countries
- China
Study Locations
More Related Trials
-
Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome
NCT04087200 ·Status: RECRUITING
-
PCSK9 Inhibitors in the Progression of Aortic Stenosis
NCT03051360 ·Status: UNKNOWN ·Phase: PHASE2
-
Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome
NCT05298475 ·Status: UNKNOWN ·Phase: PHASE4
-
Guided Optimisation of Long-term Disease rEduction in secoNdary Prevention of CVD
NCT06637657 ·Status: RECRUITING
-
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
NCT06863545 ·Status: RECRUITING ·Phase: NA
-
How Atorvastatin Affects the Gut Flora and Metabolomics?
NCT04215237 ·Status: UNKNOWN ·Phase: NA
-
Acute Myocardial Infarction and Unstable Angina Patients With PCSK9 Inhibitor Usage Study
NCT04730648 ·Status: UNKNOWN ·Phase: NA
-
Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
NCT02888652 ·Status: COMPLETED
-
Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)
NCT02360956 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pilot Study Exploring Efficacy and Safety of Amlodipine in the Stented Angina Patients
NCT01120327 ·Status: COMPLETED ·Phase: PHASE4
-
A Study for Exploring the Efficacy of Naoxintong Capsules in the Treatment of Coronary Atherosclerotic Plaque on the Basis of Optimal Medical Therapy (Aspirin,Statins,Clopidogrel, Etc.): Stage One
NCT05278182 ·Status: UNKNOWN ·Phase: NA
-
COAST Study - Cholesterol Optimization After Stroke
NCT07256171 ·Status: NOT_YET_RECRUITING
-
Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence Tomography
NCT04851769 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Pleiotropic Effect of Statins in Patients With Peripheral Arterial Disease
NCT01041729 ·Status: COMPLETED ·Phase: PHASE4
-
High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients
NCT05912686 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI
NCT01033058 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Simvastatin on Cardiac Function
NCT01178710 ·Status: COMPLETED ·Phase: NA
-
China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension
NCT03532620 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluate the Efficacy of Fenofibrate on Microalbuminuria
NCT02314533 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Atorvastatin and Lifestyle Intervention on Progression of Pre-Clinical Atherosclerosis
NCT00723320 ·Status: UNKNOWN ·Phase: NA
-
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2
NCT01058057 ·Status: UNKNOWN ·Phase: PHASE3
-
Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention
NCT06281041 ·Status: COMPLETED
-
Retrospective Analysis of the Effect of In-hospital Initiation of PCSK9i on Clinical Outcomes in Chinese ACS Patients
NCT06567418 ·Status: RECRUITING
-
Protective Effect of Statin Against Negative Cardiovascular Remodeling and Organ Dysfunction After Acute Aortic Syndrome Surgery (PANDA III)
NCT04699279 ·Status: RECRUITING ·Phase: NA
-
Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents
NCT04250116 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4